BD and Pharmatrade deploy first robot pharmacy system in UAE
BD (Becton, Dickinson and Company) and regional distributor Pharmatrade have launched what they describe as the UAE's first robot-automated retail pharmacy, installing a BD Rowa system at Community Health Solutions Pharmacy inside Dubai's Wafi Mall. The deployment automates medication storage, retrieval and inventory management, with the site also designated as a reference installation for future rollout across retail and hospital pharmacies in the UAE and wider Middle East region.
The BD Rowa platform is an established product line in European and North American pharmacy markets, where robotic dispensing has become commonplace in high-volume settings. The system handles stock rotation, traceability and inventory control without manual intervention, freeing dispensing staff to spend more time on patient-facing consultations. BD says the technology reduces picking errors and improves stock visibility, though the company did not release specific accuracy or throughput figures for the CHS installation.
Partnership and regional ambition
Ashraf Al Jaabari, vice president of Pharmacy Automation for the META region at BD, said the partnership with Pharmatrade represents "an important step in advancing pharmacy automation across the region and helping pharmacies evolve around what matters most: the patients who rely on them for care." Jihad Hussami, senior executive director at Pharmatrade, described the milestone as evidence that "smart technology can transform the way pharmacies operate and serve their customers."
The UAE's broader healthcare modernisation agenda, which includes targets set under the country's Vision 2031 framework, is driving demand for technology-enabled clinical infrastructure across both public and private settings. Pharmacy automation is one part of a wider push that encompasses electronic health records, telemedicine and AI-assisted diagnostics.
Market context
Robotic dispensing is not new globally. European hospital and retail pharmacy networks have operated BD Rowa and competing systems from suppliers such as Omnicell and Swisslog for well over a decade. The Middle East and North Africa market has, however, been slower to adopt, partly owing to regulatory variation across Gulf Cooperation Council states and the dominance of independent pharmacy operators who may lack the capital or volume to justify automation investment.
The choice of a Wafi Mall retail site, rather than a hospital pharmacy, is a signal that the economics of automation are becoming viable at smaller throughput levels. If CHS's reference-site model succeeds in generating measurable data on dispensing speed and error reduction, it could accelerate adoption among the UAE's private pharmacy chains, several of which operate dozens of outlets. BD and Pharmatrade did not disclose commercial terms or the value of the installation contract, nor did they outline a timeline for further deployments in the region.
For BD, the UAE launch extends a pharmacy automation business that sits alongside its broader medical technology portfolio. The company reported group revenues of approximately $20 billion in its most recent financial year, with the medication management and pharmacy automation segment representing a meaningful but minority share of that total. Regional market development deals of this nature are typically low in immediate revenue impact but carry strategic value as reference sites that support larger tender bids in hospital networks.